Rapid Micro Biosystems, Inc. RPID
1.11
0.00
0.00%
as of 25 Sep
- Market cap
- $55.7M
- P/E
- 0.0×
Follow RPID
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (141.65%) | (116.74%) | (86.82%) | (68.83%) |
+8 more TTM periods Free account |
|
| (76.40%) | (67.84%) | (54.47%) | (46.56%) | ||
ROIC |
(181.64%) | (187.79%) | (214.45%) | (129.52%) | |
Return on Tangible Assets |
(141.15%) | (128.96%) | (91.23%) | (70.32%) | |
Average Days of Receivables |
57.23 | 67.59 | 34.06 | 64.93 | |
Free Cash Flow per Share |
(0.84) | (0.84) | (0.71) | (0.86) | |
Free Cash Flow |
(40.39) | (37.98) | (31.91) | (38.58) | |
Capital Expenditures |
(0.34) | (0.92) | (0.85) | (0.86) | |
Piotroski F-Score |
2.00 | 2.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(70.71%) | (59.38%) | (34.36%) | (36.13%) | |
Accounts Receivable Turnover |
6.08 | 6.32 | 6.31 | 6.66 | |
Accounts Payable Turnover |
7.81 | 9.14 | 9.75 | 9.51 | |
Inventory Turnover |
1.68 | 1.75 | 1.72 | 1.33 | |
Average Days of Payables |
56.87 | 51.08 | 46.43 | 46.55 | |
Days of Inventory on Hand |
207.83 | 190.83 | 197.34 | 273.01 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
38.21% | 38.79% | 40.50% | 45.16% | |
Selling, General and Administrative Expense of Revenue |
108.79% | 108.36% | 103.72% | 111.33% | |
Share Based Compensation of Revenue |
12.27% | 12.26% | 12.01% | 13.42% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 0.74 | 0.66 | 0.85 | |
Depreciation/Fixed assets |
0.39 | 0.36 | 0.36 | 0.35 | |
Capex/Depreciation |
(0.11) | (0.29) | (0.26) | (0.26) | |
Revenue per Share |
0.73 | 0.76 | 0.75 | 0.68 | |
Operating CF per Share |
(0.83) | (0.82) | (0.70) | (0.84) | |
Capex per Share |
(0.01) | (0.02) | (0.02) | (0.02) | |
Capex to Sales |
0.01 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
(145.55%) | (145.81%) | (140.30%) | (145.11%) |
Columns are period end dates